Agency Forms Undergoing Paperwork Reduction Act Review, 68885-68886 [2014-27351]

Download as PDF Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices appointment of Performance Review Board Members be published in the Federal Register. The following persons may be named to serve on the Performance Review Boards or Panels, which oversee the evaluation of performance appraisals of Senior Executive Service members of the Department of Health and Human Services. Employee last name Downing Foster Gabriel Gentile Gibson Gill Gracia Gunderson Haseltine McCabe McDaniel Novy Potts Seshamani Teti Weber Ziegler-Ragland Employee first name Gregory Robert Edward John Ventris John Nadine Nancy Amy William Eileen Steve Oliver Meena Catherine Mark Cheryl Date: November 14, 2014. John W. Gill, Deputy Assistant Secretary for Human Resources. [FR Doc. 2014–27405 Filed 11–17–14; 11:15 am] BILLING CODE 4151–17–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–15–14ARJ] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Clinic Context Matters Study—New— National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Background and Brief Description The daily use of specific antiretroviral medications by persons without HIV infection, but at high risk of sexual or injection exposure to HIV, has been 68885 shown to be a safe and effective HIV prevention method. The Food and Drug Administration approved the use of Truvada® for preexposure prophylaxis PrEP) in July 2012 and CDC has issued Public Health Service clinical practice guidelines for its use. Because approximately 50,000 new HIV infections continue to occur in the U.S. each year, with rates of HIV infection increasing most rapidly for young MSM and because severe disparities in HIV infection continue among African-American men and women, incorporation of PrEP into HIV prevention is important. However, as a prevention tool in very early stages of introduction and use, there is much we need to learn about how to implement PrEP in real-world settings. CDC is requesting OMB approval to collect data over a 3-year period that will be used to conduct research among clinicians about their knowledge, attitudes, and practices related to a new intervention (PrEP) over the period of its initial introduction in their clinics. The knowledge gained will be used to refine measurement instruments and methods (for example, identify modifications to questions in the current surveys that are unclear to participants), develop training and educational resources and tools for use by CDC/DHAP (Division of HIV/AIDS Prevention)-funded partners, and other organizations supporting delivery of PrEP in clinical settings. The project will be conducted in clinics in each of four cities (Houston, Newark, Chicago, and Philadelphia) where PrEP has recently become available at local community health centers. Once per year for 3 years, CDC will conduct an online survey of clinicians at participating clinics to collect data on the demographics of the respondents and their knowledge, attitudes, practices, and organizational factors related to PrEP and its delivery in their clinics. Surveys will be administered through an online survey Web site. There are no costs to respondents other than their time. The total annual burden hours are 88. ESTIMATED ANNUALIZED BURDEN HOURS mstockstill on DSK4VPTVN1PROD with NOTICES Type of respondent Form name Number of respondents Number of responses per respondent Average hours per response Clinician ........................................................... Clinician Consent and Interview .................... 175 1 30/60 VerDate Sep<11>2014 16:16 Nov 18, 2014 Jkt 235001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\19NON1.SGM 19NON1 68886 Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–27351 Filed 11–18–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–15–0234] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencyies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project National Ambulatory Medical Care Survey (NAMCS), (OMB No. 0920–0234 exp. 12/31/2014)—Revision—National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Background and Brief Description Section 306 of the Public Health Service (PHS) Act (42 U.S.C. 242k), as amended, authorizes that the Secretary of Health and Human Services, acting through NCHS, shall collect statistics on the utilization of health care provided by non-federal office-based physicians in the United States. On December 13, 2011, the OMB approved data collection for three years from 2012 to 2014. This revision is to request approval to continue NAMCS data collection activities for three years from 2015– 2017, make minor modifications to survey content, and to collect additional questions on alcohol screening practices and on provider cultural and linguistic competence. This notice also covers potential increases in sample size that might result due to other future budget allocations. The National Ambulatory Medical Care Survey (NAMCS) has been conducted intermittently from 1973 through 1985, and annually since 1989. The purpose of NAMCS, a voluntary survey, is to meet the needs and demands for statistical information about the provision of ambulatory medical care services in the United States. Ambulatory services are rendered in a wide variety of settings, including physicians’ offices and hospital outpatient and emergency departments. The NAMCS target universe consists of all office visits made by ambulatory patients to non-Federal office-based physicians (excluding those in the specialties of anesthesiology, radiology, and pathology) who are engaged in direct patient care. In 2006, physicians and mid-level providers (i.e., nurse practitioners, physician assistants, and nurse midwives) practicing in community health centers (CHCs) were added to the NAMCS sample, and these data will continue to be collected. To complement NAMCS data, NCHS initiated the National Hospital Ambulatory Medical Care Survey (NHAMCS, OMB No. 0920–0278) in 1992 to provide data concerning patient visits to hospital outpatient and emergency departments. NAMCS and NHAMCS are the principal sources of data on ambulatory care provided in the United States. The annualized estimated burden of time is 25,311 hours. There is no cost to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Office-based physicians (Core plus Expansion Sample). Physician Induction Interview (NAMCS–1) .... Patient Record form (NAMCS–30) (Physician abstracts on Web). Pulling, re-filing medical record forms (FR abstracts). Induction Interview—service delivery site (NAMCS–201). Induction Interview—Providers ...................... Patient Record form (NAMCS–30) (Provider abstracts). Pulling, re-filing medical record forms (FR abstracts). Pulling, re-filing medical record forms (FR abstracts). mstockstill on DSK4VPTVN1PROD with NOTICES Community Health Centers (Core plus Expansion Sample). Re-abstraction study ....................................... VerDate Sep<11>2014 16:16 Nov 18, 2014 Jkt 235001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\19NON1.SGM Number of responses per respondent Average burden per response (in hours) 5,656 1,131 1 30 45/60 14/60 4,525 30 1/60 1,780 1 20/60 4,005 801 1 30 45/60 14/60 3,204 30 1/60 500 10 1/60 19NON1

Agencies

[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Pages 68885-68886]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27351]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-14ARJ]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Clinic Context Matters Study--New--National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The daily use of specific antiretroviral medications by persons 
without HIV infection, but at high risk of sexual or injection exposure 
to HIV, has been shown to be a safe and effective HIV prevention 
method. The Food and Drug Administration approved the use of 
Truvada[supreg] for preexposure prophylaxis PrEP) in July 2012 and CDC 
has issued Public Health Service clinical practice guidelines for its 
use.
    Because approximately 50,000 new HIV infections continue to occur 
in the U.S. each year, with rates of HIV infection increasing most 
rapidly for young MSM and because severe disparities in HIV infection 
continue among African-American men and women, incorporation of PrEP 
into HIV prevention is important. However, as a prevention tool in very 
early stages of introduction and use, there is much we need to learn 
about how to implement PrEP in real-world settings.
    CDC is requesting OMB approval to collect data over a 3-year period 
that will be used to conduct research among clinicians about their 
knowledge, attitudes, and practices related to a new intervention 
(PrEP) over the period of its initial introduction in their clinics. 
The knowledge gained will be used to refine measurement instruments and 
methods (for example, identify modifications to questions in the 
current surveys that are unclear to participants), develop training and 
educational resources and tools for use by CDC/DHAP (Division of HIV/
AIDS Prevention)-funded partners, and other organizations supporting 
delivery of PrEP in clinical settings. The project will be conducted in 
clinics in each of four cities (Houston, Newark, Chicago, and 
Philadelphia) where PrEP has recently become available at local 
community health centers. Once per year for 3 years, CDC will conduct 
an online survey of clinicians at participating clinics to collect data 
on the demographics of the respondents and their knowledge, attitudes, 
practices, and organizational factors related to PrEP and its delivery 
in their clinics. Surveys will be administered through an online survey 
Web site.
    There are no costs to respondents other than their time. The total 
annual burden hours are 88.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of
         Type of respondent                  Form name            Number of      responses per    Average hours
                                                                 respondents       respondent      per response
----------------------------------------------------------------------------------------------------------------
Clinician...........................  Clinician Consent and               175                1            30/60
                                       Interview.
----------------------------------------------------------------------------------------------------------------



[[Page 68886]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27351 Filed 11-18-14; 8:45 am]
BILLING CODE 4163-18-P